TY - JOUR
T1 - Deeper insight into ferroptosis
T2 - association with Alzheimer’s, Parkinson’s disease, and brain tumors and their possible treatment by nanomaterials induced ferroptosis
AU - Yadav, Virendra Kumar
AU - Choudhary, Nisha
AU - Gacem, Amel
AU - Verma, Rakesh Kumar
AU - Abul Hasan, Mohd
AU - Tarique Imam, Mohammad
AU - Almalki, Ziyad Saeed
AU - Yadav, Krishna Kumar
AU - Park, Hyun Kyung
AU - Ghosh, Tathagata
AU - Kumar, Pankaj
AU - Patel, Ashish
AU - Kalasariya, Haresh
AU - Jeon, Byong Hun
AU - Ali AlMubarak, Hassan
N1 - Publisher Copyright:
© 2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.
PY - 2023
Y1 - 2023
N2 - Ferroptosis is an emerging and novel type of iron-dependent programmed cell death which is mainly caused by the excessive deposition of free intracellular iron in the brain cells. This deposited free iron exerts a ferroptosis pathway, resulting in lipid peroxidation (LiPr). There are mainly three ferroptosis pathways viz. iron metabolism-mediated cysteine/glutamate, and LiPr-mediated. Iron is required by the brain as a redox metal for several physiological activities. Due to the iron homeostasis balance disruption, the brain gets adversely affected which further causes neurodegenerative diseases (NDDs) like Parkinson's and Alzheimer's disease, strokes, and brain tumors like glioblastoma (GBS), and glioma. Nanotechnology has played an important role in the prevention and treatment of these NDDs. A synergistic effect of nanomaterials and ferroptosis could prove to be an effective and efficient approach in the field of nanomedicine. In the current review, the authors have highlighted all the latest research in the field of ferroptosis, specifically emphasizing on the role of major molecular key players and various mechanisms involved in the ferroptosis pathway. Moreover, here the authors have also addressed the correlation of ferroptosis with the pathophysiology of NDDs and theragnostic effect of ferroptosis and nanomaterials for the prevention and treatment of NDDs.
AB - Ferroptosis is an emerging and novel type of iron-dependent programmed cell death which is mainly caused by the excessive deposition of free intracellular iron in the brain cells. This deposited free iron exerts a ferroptosis pathway, resulting in lipid peroxidation (LiPr). There are mainly three ferroptosis pathways viz. iron metabolism-mediated cysteine/glutamate, and LiPr-mediated. Iron is required by the brain as a redox metal for several physiological activities. Due to the iron homeostasis balance disruption, the brain gets adversely affected which further causes neurodegenerative diseases (NDDs) like Parkinson's and Alzheimer's disease, strokes, and brain tumors like glioblastoma (GBS), and glioma. Nanotechnology has played an important role in the prevention and treatment of these NDDs. A synergistic effect of nanomaterials and ferroptosis could prove to be an effective and efficient approach in the field of nanomedicine. In the current review, the authors have highlighted all the latest research in the field of ferroptosis, specifically emphasizing on the role of major molecular key players and various mechanisms involved in the ferroptosis pathway. Moreover, here the authors have also addressed the correlation of ferroptosis with the pathophysiology of NDDs and theragnostic effect of ferroptosis and nanomaterials for the prevention and treatment of NDDs.
KW - Ferroptosis
KW - Parkinson’s disorder
KW - glioblastoma
KW - glutathione
KW - neurodegenerative
UR - http://www.scopus.com/inward/record.url?scp=85178052048&partnerID=8YFLogxK
U2 - 10.1080/13510002.2023.2269331
DO - 10.1080/13510002.2023.2269331
M3 - Review article
C2 - 38010378
AN - SCOPUS:85178052048
SN - 1351-0002
VL - 28
JO - Redox Report
JF - Redox Report
IS - 1
M1 - 2269331
ER -